Notably, the two breast cancer subgroups stratified by age showed significantly different serum OPN levels, while comparing the younger breast cancer subgroup with the control and fibroadenoma groups revealed no significant difference regarding their serum OPN levels as shown in Supplementary Table S2. This evidence concerns the gene SPP1 and breast carcinoma.